000			02081nam a2200181 4500
003			OSt
005			20241108143327.0
008			241108b |||||||| |||| 00| 0 eng d
100			_aGobika Arumugam,
245			_aIdentification of Suitable Amalgamation with Resveratrol, Epigallocatechin-3-gallate, and Diallyl Trisulfide against Skin Cancer Cell Lines (A431)
300			_aP178-186
520			_a Resveratrol, Epigallocatechin -3-gallate (EGCG) and Diallyl Trisulfide (DATS) are bioactive compounds in which two polyphenols and an organosulfur are naturally occurring bioactive chemicals that can be efficacious in skin cancer chemoprevention either independently or in combination. Objectives: Conglomerate analysis of RES, EGCG, and DATS was performed as a single and in binary combinations to investigate cancer cell viability, in vitro in the A431 (human epidermoid carcinoma) skin cancer cell line. Materials and Methods: Screening of cytotoxicity potential of bioactive combinations by MTT assay, nuclear fragmentation: Acridine orange / ethidium bromide AO/EtBr assay on skin cancer cell lines (A431). Results: Our result showed that the half-maximal growth inhibitory concentration for RES-(IC50)-42 µM/mL, EGCG (IC50)-44 µM/mL, and DATS (IC50)-36 µM/mL whereas the binary combination RES + EGCG (IC50)-20 µM/mL; EGCG + DATS (IC50)-13 µM/mL; DATS + RES (IC50)-24 µM/mL which is evident from the uptake of AO and EtBr dyes by live/dead cells. Conclusion: Amalgam of RES, EGCG, and DATS can succor to develop skin cancer treatment better than as a single. Compared to all the combinations EGCG + DATS possess higher anticancer potentials against A431 skin cancer cell line.
654			_a Skin cancer _a Synergistic effect of Resveratrol _aEpigallocatechin-3-gallate, _a, Diallyl trisulfide, _a Dietary bioactive compound.
700			_a Sangilimuthu Alagar Yadav*
773	0		_0125266 _9109601 _dBanglore Association of Pharmaceutical Tearchers of India _oJP44 _tIndian Journal of Pharmaceutical Education and Research _x0019-5464
942			_cJA
942			_2ddc
999			_c130078 _d130078